Article info

Extended report
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study

Authors

  1. Correspondence to Professor Cem Gabay, Division of Rheumatology, Department of Medical Specialties, University Hospitals of Geneva, Switzerland, 26 Avenue de Beau-Séjour, 1211 Geneva 14, Switzerland; cem.gabay{at}hcuge.ch
View Full Text

Citation

Gabay C, Riek M, Hetland ML, et al
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study

Publication history

  • Received April 9, 2015
  • Revised July 22, 2015
  • Accepted July 24, 2015
  • First published September 15, 2015.
Online issue publication 
June 10, 2016

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.